Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 12/20 | 1.00 |
| ▸ | CNR1 | P21554 | 11/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 7/20 | 1.00 |
| ▸ | GPR55 | Q9Y2T6 | 4/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 2/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | GPR6 | P46095 | 1/20 | 1.00 |
| ▸ | NAAA | Q02083 | 1/20 | 1.00 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 1.00 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 1.00 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 1.00 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 1.00 |
| ▸ | MLNR | O43193 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabidivarin SCHEMBL22705595 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL18371742 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL17345387 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL2759238 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL243338 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL16224876 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL6857317 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL10296698 | 0.93 | CNR2 (0.86) | CNR2CNR1OPRM1GPR55TRPV1 | |
| SCHEMBL23686658 | 0.92 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| SCHEMBL22705457 | 0.92 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240269153-A1 | BIOACTIVE BIPHASIC COMPOSITIONS | NATURAL EXTRACTION SYS LLC (US) | 2024-08-15 | — | — | US | claimed |
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2024-04-25 | — | — | US | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| US-20230073802-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2023-03-09 | — | — | US | claimed |
| WO-2022251709-A1 | BIOACTIVE BIPHASIC COMPOSITIONS | Natural Extraction Systems, LLC (US) | 2022-12-01 | — | — | WO | claimed |
| WO-2022173812-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2022-08-18 | — | — | WO | claimed |
| WO-2022173901-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2022-08-18 | — | — | WO | claimed |
| WO-2021158714-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| US-20260083161-A1 | CONTAINERS THAT CONTAIN ANIONIC CANNABINOIDS | NATURAL EXTRACTION SYS LLC (US) | 2026-03-26 | — | — | US | disclosed |
| US-12484606-B2 | Compositions and methods related to anionic cannabinoid molecules | Natural Extraction Systems, LLC (US) | 2025-12-02 | — | — | US | disclosed |
| US-20250090494-A1 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | NORAMCO, LLC | 2025-03-20 | — | — | US | disclosed |
| US-20240269153-A1 | BIOACTIVE BIPHASIC COMPOSITIONS | NATURAL EXTRACTION SYS LLC (US) | 2024-08-15 | — | — | US | disclosed |
| EP-3763361-B1 | CANNABIDIVARIN (CBDV) FOR USE IN THE TREATMENT OF EPILEPSY | GW PHARMA LTD (GB) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024112694-A1 | RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS | WILLOW BIOSCIENCES, INC. (CA) | 2024-05-30 | — | — | WO | disclosed |
| WO-2020123976-A1 | COMPOSITIONS AND METHODS RELATED TO ANIONIC CANNABINOID MOLECULES | Natural Extraction Systems, LLC (US) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020123809-A1 | COMPOSITIONS AND METHODS RELATED TO ANIONIC CANNABINOID MOLECULES | Natural Extraction Systems, LLC (US) | 2020-06-18 | — | — | WO | disclosed |
| WO-2019180706-A1 | METHODS AND COMPOSITIONS FOR TREATING EPILEPSY AND ASSOCIATED DISORDERS | BOL PHARMA LTD. (IL) | 2019-09-26 | — | — | WO | disclosed |
| EP-2782563-B1 | TETRAHYDROCANNABIVARIN FOR USE IN THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES | GW PHARMA LTD (GB) | 2018-04-25 | — | — | EP | disclosed |
| US-9815810-B1 | Method of cannabinoid preservation through crystallization and other crystal structures | Deep Cell Industries Inc. (US) | 2017-11-14 | — | — | US | disclosed |
| WO-2017178807-A1 | USE OF CANNABIDIVARIN IN THE TREATMENT OF AUTISM SPECTRUM DISORDER, ASSOCIATED DISORDERS AND SCHIZOPHRENIA | GW Research Limited (GB) | 2017-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250090494-A1 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | MGLL, CNR2, HDHD5 | CNR2 2/4885CNR1 4/4885OPRM1 40/4885 |
| US-20260083161-A1 | CONTAINERS THAT CONTAIN ANIONIC CANNABINOIDS | CNR2, CNR1, OPRD1 | CNR2 1/4885CNR1 2/4885OPRM1 4/4885 |
| US-12484606-B2 | Compositions and methods related to anionic cannabinoid molecules | CNR2, CNR1, PHOSPHO1 | CNR2 1/4885CNR1 2/4885OPRM1 12/4885 |
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | CNR1, CNR2, OPRD1 | CNR2 2/4885CNR1 1/4885OPRM1 5/4885 |
| US-20230073802-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885OPRM1 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.